Moleculin Biotech Management
Management criteria checks 3/4
Moleculin Biotech's CEO is Wally Klemp, appointed in Jul 2015, has a tenure of 9.25 years. total yearly compensation is $1.41M, comprised of 39.9% salary and 60.1% bonuses, including company stock and options. directly owns 2.56% of the company’s shares, worth $179.42K. The average tenure of the management team and the board of directors is 7 years and 7.3 years respectively.
Key information
Wally Klemp
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 39.9% |
| CEO tenure | 9.3yrs |
| CEO ownership | 2.6% |
| Management average tenure | 7yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$25m |
| Mar 31 2024 | n/a | n/a | -US$27m |
| Dec 31 2023 | US$1m | US$565k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$26m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$30m |
| Dec 31 2022 | US$2m | US$565k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$25m |
| Jun 30 2022 | n/a | n/a | -US$21m |
| Mar 31 2022 | n/a | n/a | -US$18m |
| Dec 31 2021 | US$2m | US$538k | -US$16m |
| Sep 30 2021 | n/a | n/a | -US$16m |
| Jun 30 2021 | n/a | n/a | -US$15m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | US$2m | US$500k | -US$17m |
| Sep 30 2020 | n/a | n/a | -US$19m |
| Jun 30 2020 | n/a | n/a | -US$19m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$2m | US$625k | -US$13m |
| Sep 30 2019 | n/a | n/a | -US$12m |
| Jun 30 2019 | n/a | n/a | -US$10m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$1m | US$403k | -US$12m |
| Sep 30 2018 | n/a | n/a | -US$12m |
| Jun 30 2018 | n/a | n/a | -US$13m |
| Mar 31 2018 | n/a | n/a | -US$11m |
| Dec 31 2017 | US$1m | US$325k | -US$10m |
Compensation vs Market: Wally's total compensation ($USD1.41M) is above average for companies of similar size in the UK market ($USD369.83K).
Compensation vs Earnings: Wally's compensation has been consistent with company performance over the past year.
CEO
Wally Klemp (64 yo)
9.3yrs
Tenure
US$1,414,599
Compensation
Mr. Walter V. Klemp, also known as Wally, has been the Executive Chairman of Autonomix Medical, Inc. since joining in January 2022. He Co-Founded Moleculin Biotech, Inc. in July 2015 and has been its Chief...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.3yrs | US$1.41m | 2.56% $ 179.4k | |
| Executive VP & CFO | 8.2yrs | US$840.64k | 0.40% $ 28.0k | |
| Chief Scientific Officer | 7.2yrs | US$599.11k | 0.28% $ 19.7k | |
| Co-Founder | no data | no data | no data | |
| Senior Chief Medical Officer | 3yrs | no data | no data | |
| Chief Medical Officer of New Products | 6.9yrs | no data | no data | |
| European Chief Medical Officer | 2.4yrs | no data | no data |
7.0yrs
Average Tenure
69yo
Average Age
Experienced Management: 0K2H's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.3yrs | US$1.41m | 2.56% $ 179.4k | |
| Co-Founder | no data | no data | no data | |
| Independent Director | 8.3yrs | US$68.52k | 0% $ 0 | |
| Lead Independent Director | 7.3yrs | US$81.05k | 0% $ 0 | |
| Independent Director | 4yrs | US$63.52k | 0% $ 0 | |
| Member of Annamycin Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 8.3yrs | US$74.90k | 0.034% $ 2.4k | |
| Independent Director | 2.6yrs | US$47.15k | 0% $ 0 |
7.3yrs
Average Tenure
65yo
Average Age
Experienced Board: 0K2H's board of directors are considered experienced (7.3 years average tenure).